Navigation Links
Drug Reduces Complications in Surgical Abortions: Study
Date:3/7/2012

WEDNESDAY, March 7 (HealthDay News) -- The drug misoprostol reduced major complications from early surgical abortion by nearly one-third, according to a new study.

Doctors often use misoprostol for cervical preparation prior to surgical abortion (vacuum aspiration). Until now, however, there were no studies large enough to determine whether the drug reduces the risk of serious complications, either immediate or delayed, according to background information in the study published in the March 8 online edition of The Lancet.

For the study, researchers from the World Health Organization (WHO) in Geneva compared rates of complications among nearly 5,000 women in nine countries who underwent surgical abortion before 12 weeks of gestation. Complications included cervical tear, uterine perforation, incomplete abortion and pelvic inflammatory disease.

Women were randomly assigned to receive either vaginal misoprostol or an inactive "placebo" three hours before the procedure.

The women in the misoprostol group were nearly one-third less likely to experience one or more complications compared to the women who received a placebo, and the risk of incomplete abortion was nearly three times higher among the women in the placebo group, the investigators found.

Women in the misoprostol group, however, were more likely to experience abdominal pain, vaginal bleeding and nausea in the three hours before surgery.

"Misoprostol reduced the overall incidence of complications, particularly incomplete abortions and unscheduled clinic visits and hospital admissions, after abortion," concluded study author Eduardo Bergel and colleagues, in a journal news release. "Providers should be aware of the side effects of the drug and inform women about these effects."

In an accompanying editorial, Dr. Allan Templeton, professor of obstetrics and gynecology at the University of Aberdeen in Scotland, wrote: "The important ongoing issue is . . . the balance between effectiveness of the procedure and the side effects of misoprostol, which will include abdominal cramps and vaginal bleeding in most women, although not to the extent of needing medical intervention before surgery."

The findings of this study suggest that "routine pharmaceutical dilation of the cervix should be recommended as an integral part of surgical abortion in all women," Templeton added.

More information

The U.S. National Library of Medicine has more about surgical abortion.

-- Robert Preidt

SOURCE: The Lancet, news release, March 7, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Service Foods Reduces its Carbon Footprint and Grows Sales
2. Health Care Reform Report Covers Uninsured, Reduces Costs
3. New cardiac CT technology drastically reduces patient radiation exposure
4. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
5. Targeted delivery of losartan reduces liver inflammation and scarring
6. Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
7. Soccer reduces risk of falls and bone fractures
8. Pioneering treatment reduces disability in premature babies with serious brain hemorrhage
9. New drug candidate reduces blood lipids
10. PSA Test Reduces Prostate Cancer Deaths by 40%
11. New technique reduces tobacco smoke damage to lungs in mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Reduces Complications in Surgical Abortions: Study
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: